Bradycardia
212
42
53
119
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
41 trials with published results (19%)
Research Maturity
119 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
7 terminated out of 212 trials
94.4%
+7.9% vs benchmark
11%
23 trials in Phase 3/4
34%
41 of 119 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 119 completed trials
Clinical Trials (212)
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
HeartBeam ECG Registry
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
LEAP 2 Chronic EFS
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
BIO|STREAM.CSP Study
Comparison of Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
PV Loops With CNT in Multiple Pacing Sites
Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)
Moderato System: A Double-Blind Randomized Trial Ver 1.1
Impact of Swaddle Blanket on Gastroesophageal Reflux
Aveir DR i2i Study
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
Aveir DR Real-World Evidence Post-Approval Study
Aveir VR Real-World Evidence Post-Approval Study
Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction
Impact of Allometric Pacing Rate on Ventricular Diastolic Function and Cerebral Blood Flow in Hypertensive Patients With Sinus Node Dysfunction
Dexmedetomidine vs Propofol in High-Risk ERCP Patients